Literature DB >> 19818961

Apolipoprotein E genotype is associated with serum C-reactive protein but not abdominal aortic aneurysm.

Jonathan Golledge1, Erik Biros, Matthew Cooper, Nicole Warrington, Lyle J Palmer, Paul E Norman.   

Abstract

OBJECTIVE: Apolipoprotein E (ApoE) genotype has been associated with systemic inflammation and athero-thrombosis however the association with abdominal aortic aneurysm (AAA) has not been previously examined. We assessed the association between ApoE genotype with AAA presence and growth, and serum C-reactive protein (CRP).
METHODS: Serum concentrations of CRP (in 1358 men) and 6 single nucleotide polymorphisms (SNPs) for ApoE (in 1711 men) were examined in subjects from the Health In Men Study. 640 men with small AAAs were followed by ultrasound surveillance for a mean of 4.1 years.
RESULTS: There was no association between ApoE genotype and AAA presence. Men heterozygote for the ApoE p.Arg176Cys polymorphism had slower AAA growth, odds ratio for AAA progression> or =median 0.41, 95% confidence intervals 0.21-0.80, p=0.01. Men heterozygote for the ApoE g.50093756A>G polymorphism had slightly more rapid AAA growth, odds ratio for AAA progression> or =median 1.48, 95% confidence intervals 1.02-2.14, p=0.04. None of the ApoE SNPs were associated with AAA growth however taking into account multiple testing. Two SNPs in ApoE were associated with serum CRP under a co-dominant model, ApoE p.Cys130Arg (SNP ID rs429358), p=0.00003 and ApoE g.50114786A>G (SNP ID rs4420638), p=0.00013. Adjusting for other risk factors plus serum creatinine the varepsilon4 allele was associated with lower serum CRP under a dominant model, coefficient 0.089, p=0.002.
CONCLUSION: We found no consistent association between ApoE genotype and AAA. We confirmed an association between ApoE genotype and serum CRP. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19818961      PMCID: PMC2846218          DOI: 10.1016/j.atherosclerosis.2009.09.027

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  30 in total

Review 1.  The role of apolipoprotein E and lipoprotein receptors in modulating the in vivo metabolism of apolipoprotein B-containing lipoproteins in humans.

Authors:  R E Gregg; H B Brewer
Journal:  Clin Chem       Date:  1988       Impact factor: 8.327

2.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

3.  Screening for abdominal aortic aneurysm: lessons from a population-based study.

Authors:  K Jamrozik; P E Norman; C A Spencer; R W Parsons; R Tuohy; M M Lawrence-Brown; J A Dickinson
Journal:  Med J Aust       Date:  2000-10-02       Impact factor: 7.738

Review 4.  Apolipoprotein E: far more than a lipid transport protein.

Authors:  R W Mahley; S C Rall
Journal:  Annu Rev Genomics Hum Genet       Date:  2000       Impact factor: 8.929

5.  Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice.

Authors:  Miguel A Ortiz; Gonzalo L Campana; John R Woods; George Boguslawski; Marcelo J Sosa; Candace L Walker; Carlos A Labarrere
Journal:  Exp Biol Med (Maywood)       Date:  2009-04-09

6.  Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis.

Authors:  J Dallongeville; S Lussier-Cacan; J Davignon
Journal:  J Lipid Res       Date:  1992-04       Impact factor: 5.922

7.  Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease.

Authors:  Yiqing Song; Meir J Stampfer; Simin Liu
Journal:  Ann Intern Med       Date:  2004-07-20       Impact factor: 25.391

8.  C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men.

Authors:  Paul Norman; Carole A Spencer; Michael M Lawrence-Brown; Konrad Jamrozik
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

9.  Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3.

Authors:  T Mazzone; C Reardon
Journal:  J Lipid Res       Date:  1994-08       Impact factor: 5.922

10.  Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm.

Authors:  Paul E Norman; Konrad Jamrozik; Michael M Lawrence-Brown; Max T Q Le; Carole A Spencer; Raywin J Tuohy; Richard W Parsons; James A Dickinson
Journal:  BMJ       Date:  2004-11-15
View more
  7 in total

1.  Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors?

Authors:  Jonathan Golledge; Paul E Norman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-06       Impact factor: 8.311

Review 2.  Genes and abdominal aortic aneurysm.

Authors:  Irene Hinterseher; Gerard Tromp; Helena Kuivaniemi
Journal:  Ann Vasc Surg       Date:  2010-12-13       Impact factor: 1.466

3.  Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset.

Authors:  Daniel Johnstone; Elizabeth A Milward; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

4.  Genetic determinants of long-term changes in blood lipid concentrations: 10-year follow-up of the GLACIER study.

Authors:  Tibor V Varga; Emily Sonestedt; Dmitry Shungin; Robert W Koivula; Göran Hallmans; Stefan A Escher; Inês Barroso; Peter Nilsson; Olle Melander; Marju Orho-Melander; Frida Renström; Paul W Franks
Journal:  PLoS Genet       Date:  2014-06-12       Impact factor: 5.917

5.  Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk.

Authors:  Oddgeir L Holmen; He Zhang; Yanbo Fan; Daniel H Hovelson; Ellen M Schmidt; Wei Zhou; Yanhong Guo; Ji Zhang; Arnulf Langhammer; Maja-Lisa Løchen; Santhi K Ganesh; Lars Vatten; Frank Skorpen; Håvard Dalen; Jifeng Zhang; Subramaniam Pennathur; Jin Chen; Carl Platou; Ellisiv B Mathiesen; Tom Wilsgaard; Inger Njølstad; Michael Boehnke; Y Eugene Chen; Gonçalo R Abecasis; Kristian Hveem; Cristen J Willer
Journal:  Nat Genet       Date:  2014-03-16       Impact factor: 38.330

6.  Impact of the Apolipoprotein E (epsilon) Genotype on Cardiometabolic Risk Markers and Responsiveness to Acute and Chronic Dietary Fat Manipulation.

Authors:  Kumari M Rathnayake; Michelle Weech; Kim G Jackson; Julie A Lovegrove
Journal:  Nutrients       Date:  2019-09-01       Impact factor: 5.717

7.  Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers.

Authors:  Carlo Sidore; Fabio Busonero; Andrea Maschio; Eleonora Porcu; Silvia Naitza; Magdalena Zoledziewska; Antonella Mulas; Giorgio Pistis; Maristella Steri; Fabrice Danjou; Alan Kwong; Vicente Diego Ortega Del Vecchyo; Charleston W K Chiang; Jennifer Bragg-Gresham; Maristella Pitzalis; Ramaiah Nagaraja; Brendan Tarrier; Christine Brennan; Sergio Uzzau; Christian Fuchsberger; Rossano Atzeni; Frederic Reinier; Riccardo Berutti; Jie Huang; Nicholas J Timpson; Daniela Toniolo; Paolo Gasparini; Giovanni Malerba; George Dedoussis; Eleftheria Zeggini; Nicole Soranzo; Chris Jones; Robert Lyons; Andrea Angius; Hyun M Kang; John Novembre; Serena Sanna; David Schlessinger; Francesco Cucca; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2015-09-14       Impact factor: 38.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.